Scoop has an Ethical Paywall
Geneious Biologics presents at conference in San Diego
Geneious Biologics presents at Antibody Engineering & Therapeutics conference in San Diego
AUCKLAND, NZ – November 29, 2017 –
Biomatters Vice President of Technology Services, Jannick
Bendtsen, PhD, will present at the Antibody Engineering &
Therapeutics conference on December 13, at the
Manchester Grand Hyatt in San Diego, CA.
Dr Bendtsen is the development leader of Geneious Biologics, an enterprise software as a service (SaaS) solution for screening antibodies and antibody-like constructs created by Biomatters, and will deliver a scientific briefing titled Scalable Sequence Data Analysis for Accelerated Precision Antibody Discovery.
His talk will examine how next-generation sequencing (NGS) technologies will provide the ability to comprehensively characterize and evaluate the diversity and quality of antibody libraries, accelerating identification of potential drug candidates.
Scientific Briefing: Scalable Sequence
Data Analysis for Accelerated Precision Antibody
Discovery
Presenter: Jannick Bendtsen,
PhD, Vice President of Technology Services,
Biomatters
Event: Antibody Engineering &
Therapeutics
Location: Manchester Grand
Hyatt, San Diego
Date: 13 December 2017
Time: 1:45 PM (PT), Hillcrest
Room
ends
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
University of Auckland: NZ Researchers Drive Work On International AI Framework
Woolworths: Rolling Out Team Safety Cameras To All Stores As Critical Tool For De-escalating Conflict 
Consumer NZ: Environmentally Conscious Shoppers At Risk Of Being Greenwashed
Hugh Grant: Facing The Future - The Use Of Biometric Tech
